HOOKIPA Pharma Inc. Gains 24%
Fri, Feb 18, 2022 at 05:30 PM
HOOKIPA Pharma Inc. (HOOK:NASDAQ) jumped higher at $2.48, representing a gain of 24%. The stock got featured on our News Catalysts scanner on Tue, Feb 15, 2022 at 04:41 PM in the 'AGREEMENT' category. From Fri, Feb 04, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days
About HOOKIPA Pharma Inc. (HOOK:NASDAQ)
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Top 10 Gainers:
- Sky Harbour Group Corporation Class A (SKYH:NYSEMKT), 48.38%
- RISE Education Cayman Ltd (REDU:NASDAQ), 39.71%
- HOOKIPA Pharma Inc. (HOOK:NASDAQ), 24%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 23.81%
- Amplitude Inc. (AMPL:NASDAQ), 20.82%
- Maris-Tech Ltd. (MTEK:NASDAQ), 20.74%
- Cyngn Inc. (CYN:NASDAQ), 20%
- Karyopharm Therapeutics Inc. (KPTI:NASDAQ), 19.83%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 19.21%
- Flotek Industries, Inc. (FTK:NYSE), 16.3%